EMO CORT CREAM 2.5% 2.5 %
HYDROCORTISONE : 2.5 % · DIN 00595799 · GLAXOSMITHKLINE INC
Health Canada status: CANCELLED POST MARKET
What is EMO CORT CREAM 2.5%?
EMO CORT CREAM 2.5% 2.5 % contains HYDROCORTISONE : 2.5 %. It is listed in the Health Canada Drug Product Database under DIN 00595799, held by GLAXOSMITHKLINE INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EMO CORT CREAM 2.5% used for?
Topical therapy of corticosteroid responsive dermatoses for a maximum duration of 4 weeks, where anti-inflammatory and antipruritic activity is required.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00595799 |
|---|---|
| Brand name | EMO CORT CREAM 2.5% |
| Generic / active ingredient | HYDROCORTISONE : 2.5 % |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 2.5 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AA02 HYDROCORTISONE |
| AHFS class | 84:06.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Sep-2017 |
| Original market date | 1983-12-31 00:00:00 |
How is it administered?
Apply a thin layer to affected areas once or twice a day for a maximum of 4 weeks. Use the minimum quantity for the shortest duration. Avoid abrupt discontinuation.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15ºC and 25ºC. Do not freeze.
How is it supplied?
Cream: 45 g plastic tube and 225 g plastic jar. Lotion: 60 mL plastic bottle.
Contraindications
Hypersensitivity to hydrocortisone or ingredients; bacterial, tubercular, fungal, viral, or parasitic skin infections; rosacea; acne vulgaris; pruritus without inflammation; application to the eye.
Warnings and precautions
Risk of HPA axis suppression and Cushing’s syndrome. Do not use under occlusion. Prolonged use may cause skin atrophy. Caution near eyes (risk of glaucoma/cataract).
What can be used instead?
Other Canadian products sharing ATC code D07AA02 HYDROCORTISONE. 3 of 34 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HYDROVAL CREAM 0.2% | 0.2 % | CREAM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | MARKETED | DIN 02242984 |
| HYDROVAL OINTMENT 0.2% | 0.2 % | OINTMENT | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | MARKETED | DIN 02242985 |
| SANDOZ HYDROCORTISONE | 2.5 % | CREAM | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02469421 |
| ALOCORT 1% - CRM | 1 % | CREAM | UCB INC | CANCELLED POST MARKET | DIN 02176408 |
| AQUACORT LOTION 2.5% | 2.5 % | LOTION | MERIT INDUSTRIES INC. | CANCELLED POST MARKET | DIN 01940120 |
| AVEENO HYDROCORTISONE ANTI-ITCH CREAM | 0.5 % | CREAM | JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02244959 |
| BARRIERE HC 1% | 1 % | JELLY ; CREAM | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00465070 |
| CORTACET CRM 0.5% | 0.5 % | CREAM | WHITEHALL-ROBINS INC. | CANCELLED POST MARKET | DIN 01932381 |
| CORTATE CRM 1% | 10 MG | CREAM | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502200 |
| CORTATE ONT 1% | 10 MG | OINTMENT | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 00502197 |
Who else supplies HYDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.